论文部分内容阅读
我院神经科于1985年6月～1986年6月从60例急性期脑梗塞患者中各30例,分别采用颈动脉注射尿激酶(UK)和常规用药(脉通+丹参)两种方法实施治疗,进行对照观察。结果表明;UK 组见效快,疗效高,早期用药效果更佳。无毒副反应,现报告如下:临床资料1.诊断依据:(1)全面病史和临床检查;(2)参照日本“鹿儿岛脑血管病计量法”比较;(3)遇可疑病例经头颅 CT 证实。2.分组情况:两组均为住院病人,发病均在一周以内,应用随机数目表分组。3.两组一般资料比较(见表1):从表1可以看出:性别差异不大,年龄在60岁以上者两组均占半数,说明脑梗塞发病与年龄成正相关.
Neurology in our hospital from June 1985 to June 1986 from 60 patients with acute cerebral infarction in 30 cases, respectively, by carotid artery injections of urokinase (UK) and conventional use (pulse + Salvia) two methods to implement Treatment, control observation. The results showed that: UK group quick, high efficacy, early medication better. Non-toxic side effects, are as follows: Clinical data 1. Diagnosis is based on: (1) a comprehensive history and clinical examination; (2) with reference to Japan’s “Kagoshima cerebrovascular disease measurement” comparison; (3) CT confirmed. 2. Grouping: Both groups were inpatients, the incidence was within a week, the use of random number table grouping. 3. The two groups of general information (see Table 1): As can be seen from Table 1: gender differences are not large, both aged 60 and over accounted for half of the two groups, indicating that the incidence of cerebral infarction and age are positively correlated.